Welcome to LookChem.com Sign In|Join Free

CAS

  • or

194851-19-9

4-[(4-BROMOTHIEN-2-YL)METHYL]MORPHOLINE is a chemical compound with the molecular formula C10H14BrNOS. It is a morpholine derivative featuring a bromothienylmethyl substituent, which may contribute to its potential pharmacological activity.
Used in Pharmaceutical Industry:
4-[(4-BROMOTHIEN-2-YL)METHYL]MORPHOLINE is used as a pharmaceutical intermediate for the synthesis of various biologically active molecules. Its unique structure, including the morpholine and bromothienylmethyl groups, suggests possible applications in developing new drugs, although further research and testing are necessary to confirm its specific properties and uses.
Safety Note:
It is important to handle 4-[(4-BROMOTHIEN-2-YL)METHYL]MORPHOLINE with caution and adhere to appropriate safety measures due to its potentially hazardous nature.

194851-19-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 194851-19-9 Structure

  • Basic information

    1. Product Name: 4-[(4-BROMOTHIEN-2-YL)METHYL]MORPHOLINE
    2. Synonyms: 4-[(4-BROMOTHIEN-2-YL)METHYL]MORPHOLINE;4-Bromo-2-(morpholin-4-ylmethyl)thiophene;4-[(4-Bromothiophen-2-yl)methyl]morpholine;XYQVGDMXJNORKK-UHFFFAOYSA-N
    3. CAS NO:194851-19-9
    4. Molecular Formula: C9H12BrNOS
    5. Molecular Weight: 262.17
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 194851-19-9.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 4-[(4-BROMOTHIEN-2-YL)METHYL]MORPHOLINE(CAS DataBase Reference)
    10. NIST Chemistry Reference: 4-[(4-BROMOTHIEN-2-YL)METHYL]MORPHOLINE(194851-19-9)
    11. EPA Substance Registry System: 4-[(4-BROMOTHIEN-2-YL)METHYL]MORPHOLINE(194851-19-9)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 194851-19-9(Hazardous Substances Data)

194851-19-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 194851-19-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,8,5 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 194851-19:
(8*1)+(7*9)+(6*4)+(5*8)+(4*5)+(3*1)+(2*1)+(1*9)=169
169 % 10 = 9
So 194851-19-9 is a valid CAS Registry Number.

194851-19-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[(4-bromothiophen-2-yl)methyl]morpholine

1.2 Other means of identification

Product number -
Other names 4-bromo-2-morpholinomethylthiophene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:194851-19-9 SDS

194851-19-9Downstream Products

194851-19-9Relevant articles and documents

INDOLE CARBOXAMIDES AS IKK2 INHIBITORS

-

Page/Page column 167-168, (2008/12/04)

The invention is directed to novel indole carboxamide compounds. Specifically, the invention is directed to compounds according to formula (I): wherein R1, R2, R3, R4, and m are as defined herein. The compounds of the invention are inhibitors of IKK2 and can be useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKKβ) activity, such as rheumatoid arthritis, asthma, rhinitis, and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting IKK2 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

Antiinflammation agents

-

Page/Page column 33-34, (2010/02/06)

Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic, infectious and cell proliferative diseases or conditions are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism, infection and cell proliferation. The subject compounds contain a fused heterobicyclic ring.

Quinazoline compounds

-

, (2008/06/13)

The invention concerns quinazoline compounds of the formula I STR1 wherein Q 1 is a 5- or 6-membered heteroaryl moiety and Q 1 optionally bears up to 3 substituents;wherein m is 1 or 2 and each R 1 may be a group such as hydrogen, halogeno and trifluorome

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 194851-19-9